STAT+: More proposed cuts to the NIH
And other critical biotech news stories, brought to you by The Readout.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Morning. Today, we talk about Arkansas making a bold move to curb PBM power, analyze Trump’s executive order in regards to drug prices, and more.
A big GLP-1 advance for Eli Lilly
A daily pill from Eli Lilly helped patients with type 2 diabetes improve their blood sugar and shed weight, the company said this morning, late-stage results that could propel the next-generation treatment onto the market.
